The telomere syndromes
Open accessAbstract
There has been mounting evidence of a causal role for telomere dysfunction in a number of degenerative disorders. Their manifestations encompass common disease states such as idiopathic pulmonary fibrosis and bone marrow failure. Although these disorders seem to be clinically diverse, collectively they comprise a single syndrome spectrum defined by the short telomere defect. Here we review the manifestations and unique genetics of telomere syndromes. We also discuss their underlying molecular mechanisms and significance for understanding common age-related disease processes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 123 cited sources checked · 0 supported · 0 flagged
- Interpretationreasoning
Telomere dysfunction plays a causal role in multiple degenerative disorders.
“There has been mounting evidence of a causal role for telomere dysfunction in a number of degenerative disorders.”
- Also stated in: § Abstract · boosted
“This Review highlights how recent discoveries in human genetics have synergized with the field of telomere biology to unequivocally establish a causal role for telomere dysfunction in several specific, common and recognizable disease contexts.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · boosted
- Premisecitation
Idiopathic pulmonary fibrosis is the most frequent disease manifestation caused by telomere defects.
“Among these, the lung disease idiopathic pulmonary fibrosis (IPF) — best known until recently by its ‘idiopathic’ adjective — is the most common manifestation of telomere-mediated disease12.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Armanios, M. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 730, 52–58 (2012). source
Not checked in the free run.
- Interpretationreasoning
Telomere length is an inherited trait.
“Because, as we discuss, telomere length is heritable, the unique inheritance patterns that distinguish these syndromes from other Mendelian disorders are also discussed.”
- Also stated in: § Heritability of telomere length in humans · plain
“These observations collectively support that telomere length is a genetically determined trait and that short telomeres are probably sufficient to cause disease phenotypes within similar thresholds to those seen in monogenic disorders.”
Quote in the paperSubstantial claim - Also stated in: § Heritability of telomere length in humans · plain
- Interpretationreasoning
Short telomeres are likely sufficient on their own to produce disease phenotypes at thresholds comparable to those in monogenic disorders.
“These observations collectively support that telomere length is a genetically determined trait and that short telomeres are probably sufficient to cause disease phenotypes within similar thresholds to those seen in monogenic disorders.”
Quote in the paperSubstantial claim - Premisenone given
TERT and TR mutations are the most frequently identified genetic defects in monogenic telomere syndromes.
“Mutations in TERT and TR are the most commonly identifiable defects in monogenic telomere syndromes.”
Quote in the paperNot a substantial claim
- Interpretationcitation
The clinically diverse telomere disorders together constitute one syndrome spectrum whose defining feature is short telomere length.
“Although these disorders seem to be clinically diverse, collectively they comprise a single syndrome spectrum defined by the short telomere defect.”
- Also stated in: § Abstract · hedged
“Because of their overlapping clinical features, it has been proposed to consider them as a single syndrome spectrum13, and here we refer to them as ‘the telomere syndromes.’”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Not checked in the free run.
- Rests on an assumption: The short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.
- Also stated in: § Abstract · hedged
- Premisenone given
Mutations in the essential telomerase genes TERT, TR, and DKC1 frequently cause human telomere syndromes.
“As described below, mutations in the genes that encode the essential telomerase components — namely, TERT, TR and DKC1 — are a common cause of human telomere syndromes.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The authors propose that at least three main mechanisms account for the varied disease phenotypes caused by telomere dysfunction.
“We propose that at least three primary mechanisms explain the diverse telomere-mediated disease phenotypes.”
Quote in the paperSubstantial claim - Premisecitation
Lung disease is highly penetrant in people with telomerase mutations, despite the lung's slow rate of cell division.
“Clinically, this is most apparent in the high penetrance of pulmonary disease in telomerase mutation carriers, even though the lung has a slow mitotic rate56,99.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [56] Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007). References 54–56 showed that lymphocyte telomere length using flow cytometry and fluorescence in situ hybridization could be a useful diagnostic marker in identifying individuals with telomere-related disease. source
Not checked in the free run.
- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- Interpretationreasoning
Most dyskeratosis congenita cases with a known genetic cause are attributable to mutations in DKC1, TINF2, TERT, or TR.
“Altogether, mutations in four genes — DKC1, TINF2, TERT and TR — account for most dyskeratosis congenita cases with an identifiable genetic defect.”
Quote in the paperNot a substantial claim - Premisecitation
Patients with dyskeratosis congenita or IPF frequently develop blood cancers, most often myelodysplasia or acute myeloid leukaemia.
“In addition, both dyskeratosis congenita and IPF patients are prone to developing haematological malignancies, commonly manifesting as myelodysplasia or acute myeloid leukaemia70,75,76.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Diaz de Leon, A. et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE 5, e10680 (2010). source
Not checked in the free run.
- cites [75] Alter, B. P., Giri, N., Savage, S. A. & Rosenberg, P. S. Cancer in dyskeratosis congenita. Blood 113, 6549–6557 (2009). source
Not checked in the free run.
- cites [76] Alder, J. K. et al. Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. PLoS Genet. 7, e1001352 (2011). source
Not checked in the free run.
- Premisecitation
Individuals with telomere syndromes have an increased susceptibility to cancer.
“Patients with telomere syndromes are cancer-prone.”
Quote in the paperSubstantial claim - Premisecitation
Most mouse studies have found short telomeres to protect against cancer rather than promote it.
“although in most mouse studies, short telomeres have been found to be cancer-protective rather than cancer-promoting80.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [80] Deng, Y., Chan, S. S. & Chang, S. Telomere dysfunction and tumour suppression: the senescence connection. Nature Rev. Cancer 8, 450–458 (2008). source
Not checked in the free run.
- Interpretationreasoning
Apart from trinucleotide repeat expansion, telomere shortening is the only other known molecular cause of genetic anticipation in autosomal-dominant disorders.
“Aside from trinucleotide repeat expansion, telomere shortening is the only other characterized molecular mechanism of genetic anticipation in autosomal-dominant disorders.”
Quote in the paperSubstantial claim - Premisecitation
In one series of classic dyskeratosis congenita, cancer was diagnosed about eleven times more often than in the general population.
“In classic dyskeratosis congenita, where it has been studied, cancer diagnoses have been estimated to occur at an 11-fold increased incidence relative to the population in one series75.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Alter, B. P., Giri, N., Savage, S. A. & Rosenberg, P. S. Cancer in dyskeratosis congenita. Blood 113, 6549–6557 (2009). source
Not checked in the free run.
- Interpretationreasoning
The anticipation seen in telomerase mutation families arises because germ-cell telomeres shorten and the shortened telomeres are passed to offspring together with the mutant telomerase gene.
“This anticipation closely parallels the progressive telomere shortening with each successive generation and occurs because telomeres shorten in germ cells, and the shortened telomeres are transmitted to progeny along with the mutant telomerase gene (Fig. 3a).”
Quote in the paperSubstantial claim - Premisecitation
Dyskeratosis congenita features short telomeres as a defining characteristic.
“Dyskeratosis congenita is characterized by the short telomere defect11,38,55.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Mitchell, J. R., Wood, E. & Collins, K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551–555 (1999). This study showed that dyskerin is essential for telomerase RNA stability and that dyskeratosis congenita cell lines have a short telomere length, linking this disease with defects in telomere maintenance. source
Not checked in the free run.
- cites [38] Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001). source
Not checked in the free run.
- cites [55] Alter, B. P. et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 110, 1439–1447 (2007). source
Not checked in the free run.
- Interpretationreasoning
The immunodeficiency caused by limited telomere length may impair cancer surveillance.
“and this immunodeficiency in turn may lead to a failure of cancer surveillance.”
Quote in the paperSubstantial claim - Premisecitation
Families carrying mutant telomerase genes show genetic anticipation.
“The most compelling evidence for the causal role of telomere shortening as a primary modifier of disease is that families with mutant telomerase genes display genetic anticipation39,83.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
Not checked in the free run.
- cites [83] Vulliamy, T. et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nature Genet. 36, 447–449 (2004). References 83 and 39 (above) showed that mutations in the essential telomerase genes cause genetic anticipation in autosomal-dominant dyskeratosis congenita. source
Not checked in the free run.
- Premisenone given
About 40% of dyskeratosis congenita cases still have no identified genetic cause.
“In ~40% of cases, dyskeratosis congenita remains genetically uncharacterized.”
Quote in the paperNot a substantial claim - Premisecitation
Telomere dysfunction produces notable phenotypes in tissues that divide slowly.
“more recently it has been recognized that telomere dysfunction causes prominent phenotypes in slow-turnover tissues97,99,100,103 (Table 2).”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- cites [100] Leri, A. et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22, 131–139 (2003). source
Not checked in the free run.
- cites [103] Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359–365 (2011). References 97 and 103 implicate short telomeres as a cause of mitochondrial dysfunction, a pathogenic mechanism that highlights a role for telomere dysfunction in slow-turnover tissues. source
Not checked in the free run.
- Premisecitation
Dysfunctional short telomeres initiate a DNA damage response similar to the one caused by double-strand breaks.
“The short, dysfunctional telomeres trigger a DNA damage response that resembles the response elicited by DNA double-strand breaks91–94.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [91] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). source
Not checked in the free run.
- cites [92] Enomoto, S., Glowczewski, L. & Berman, J. MEC3, MEC1, and DDC2 are essential components of a telomere checkpoint pathway required for cell cycle arrest during senescence in Saccharomyces cerevisiae. Mol. Biol. Cell 13, 2626–2638 (2002). source
Not checked in the free run.
- cites [93] IJpma, A. & Greider, C. W. Short telomeres induce a DNA damage response in Saccharomyces cerevisiae. Mol. Biol. Cell 14, 987–1001 (2003). source
Not checked in the free run.
- cites [94] Nautiyal, S., DeRisi, J. L. & Blackburn, E. H. The genome-wide expression response to telomerase deletion in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 99, 9316–9321 (2002). source
Not checked in the free run.
- Premisecitation
IPF patients carrying telomerase mutations have a mean age of onset of 51 years.
“In IPF patients with telomerase mutations, the mean age of onset is 51 years, although IPF can manifest as late as the ninth decade of life70,71.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [70] Diaz de Leon, A. et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE 5, e10680 (2010). source
Not checked in the free run.
- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
- Interpretationreasoning
Hoyeraal-Hreidarsson and Revesz syndromes, and probably Coats plus syndrome, belong to the same disease spectrum.
“On the basis of their overlapping clinical findings, Hoyeraal–Hreidarsson and Revesz syndromes (and probably Coats plus syndrome) represent the same spectrum of disease because retinopathy, intracranial calcifications and bone marrow abnormalities can be seen in all three disorders and occur in the setting of very short telomere length.”
Quote in the paperSubstantial claim - Premisecitation
Cancers in dyskeratosis congenita tend to arise in high-turnover tissues, especially squamous cell carcinomas of the skin, upper aerodigestive tract, and anogenital region.
“The cancer spectrum in dyskeratosis congenita has a predilection for high-turnover tissues with an increased incidence of squamous cell carcinomas of the skin, upper aerodigestive and anogenital tracts75.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [75] Alter, B. P., Giri, N., Savage, S. A. & Rosenberg, P. S. Cancer in dyskeratosis congenita. Blood 113, 6549–6557 (2009). source
Not checked in the free run.
- Premisecitation
In telomere syndrome patients, telomere length restricts how long the adaptive immune system can keep proliferating.
“Telomere length limits the long-term proliferative capacity of the adaptive immune system in patients with telomere syndromes81”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [81] Knudson, M., Kulkarni, S., Ballas, Z. K., Bessler, M. & Goldman, F. Association of immune abnormalities with telomere shortening in autosomal-dominant dyskeratosis congenita. Blood 105, 682–688 (2005). source
Not checked in the free run.
- Interpretationcitation
In about 20% of familial leukaemia cases, acute myeloid leukaemia may be the first sign of an inherited TERT or TR mutation.
“Acute myeloid leukaemia is a known complication of aplastic anaemia, but it may possibly be a first presentation of a germline mutation in TERT or TR in a subset of familial leukaemia cases (20%)77 and, at a much lower frequency, sporadic cases78.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [77] Kirwan, M. et al. Defining the pathogenic role of telomerase mutations in myelodysplastic syndrome and acute myeloid leukemia. Hum. Mutat. 30, 1567–1573 (2009). source
Not checked in the free run.
- cites [78] Calado, R. T. et al. Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc. Natl Acad. Sci. USA 106, 1187–1192 (2009). source
Not checked in the free run.
- Interpretationreasoning
Telomere-associated disease manifests prominently in the bone marrow.
“It is therefore not surprising that telomere-associated disease manifests so prominently in the bone marrow.”
Quote in the paperSubstantial claim - Interpretationreasoning
Even though short telomeres cause similar cellular outcomes-apoptosis and senescence-in different tissues, the resulting diseases look diverse.
“Although short telomeres cause similar cellular responses (namely, apoptosis and senescence) in different tissues, telomere-mediated disease manifests as apparently diverse disease processes.”
Quote in the paperSubstantial claim - Premisecitation
In human somatic cells with high telomerase activity, such as haematopoietic stem cells, telomeres usually shorten with each division and with age.
“Even in somatic human cells that are naturally enriched for telomerase activity, such as haematopoietic stem cells (HSCs), telomeres typically become shorter with each cell division and with age42,43.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [42] Chiu, C. P. et al. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14, 239–248 (1996). source
Not checked in the free run.
- cites [43] Vaziri, H. et al. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl Acad. Sci. USA 91, 9857–9860 (1994). source
Not checked in the free run.
- Premisecitation
Telomere dysfunction causes stem cell failure phenotypes in other tissues, including intestinal epithelium where it manifests as villous atrophy due to loss of crypt stem cells.
“For example, in the intestinal epithelium, it manifests as villous atrophy due to a loss of crypt stem cells36,101,118.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
Not checked in the free run.
- cites [101] Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999). source
Not checked in the free run.
- cites [118] Choudhury, A. R. et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nature Genet. 39, 99–105 (2007). source
Not checked in the free run.
- Premisecitation
Cell turnover in the haematopoietic compartment is remarkably high, with an estimated 10^9 cells produced per hour.
“Cell turnover is remarkably high in the haematopoietic compartment, where an estimated 109 cells are produced every hour113.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [113] Metcalf, D. The Molecular Control of Blood Cells 1–22 (Harvard Univ. Press, 1988).
Not checked in the free run.
- Premisecitation
Between 3% and 5% of aplastic anaemia patients have mutations in TERT or TR.
“In addition, 3–5% of aplastic anaemia patients carry mutant TERT and TR genes41,72,73.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [41] Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413–1424 (2005). This study identified TERT mutations in patients with aplastic anaemia. source
Not checked in the free run.
- cites [72] Du, H. Y. et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 113, 309–316 (2008). source
Not checked in the free run.
- cites [73] Yamaguchi, H. et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. Blood 102, 916–918 (2003). This study identified TR mutations in patients with bone marrow failure. source
Not checked in the free run.
- Premisecitation
Even with normal telomerase levels, only a few telomeres are typically elongated in a given cell cycle or generation.
“Even at wild-type levels, telomerase generally elongates only a few telomeres in any given cell cycle or generation34,36.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [34] Teixeira, M. T., Arneric, M., Sperisen, P. & Lingner, J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 117, 323–335 (2004). source
Not checked in the free run.
- cites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
Not checked in the free run.
- Interpretationcitation
The telomerase-knockout mouse is a valuable model for studying telomere-mediated disease mechanisms because its phenotypes closely match those in humans.
“The telomerase-knockout mouse has provided an important model for understanding telomere-mediated disease mechanisms because there is a remarkable convergence with human disease phenotypes (an overview is shown in Table 2)36,82,84,85,97,99–111.”
Quote in the paperSubstantial claim0 of 10 sources checked- cites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
Not checked in the free run.
- cites [82] Armanios, M. et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 85, 823–832 (2009). source
Not checked in the free run.
- cites [84] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997). source
Not checked in the free run.
- cites [85] Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998). References 84 and 85 are two landmark papers that established that telomerase itself is not essential and that short telomeres cause apoptosis and cell loss in high-turnover tissues. source
Not checked in the free run.
- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- cites [100] Leri, A. et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 22, 131–139 (2003). source
Not checked in the free run.
- cites [101] Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999). source
Not checked in the free run.
- cites [102] Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N. & DePinho, R. A. Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287, 1253–1258 (2000). source
Not checked in the free run.
- cites [103] Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359–365 (2011). References 97 and 103 implicate short telomeres as a cause of mitochondrial dysfunction, a pathogenic mechanism that highlights a role for telomere dysfunction in slow-turnover tissues. source
Not checked in the free run.
- Premisecitation
Telomerase acts preferentially on the shortest telomeres.
“Responding to cis-regulatory mechanisms mediated through the telomere DNA–protein complex, telomerase preferentially elongates the shortest telomeres, so only a subset of telomeres may be elongated in any cell cycle34.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Teixeira, M. T., Arneric, M., Sperisen, P. & Lingner, J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 117, 323–335 (2004). source
Not checked in the free run.
- Interpretationreasoning
The shortest telomeres play a genetically dominant role in determining cellular phenotypes.
“The shortest telomeres hence have a genetically dominant role in determining cellular phenotypes.”
Quote in the paperSubstantial claim - Premisecitation
In cultured human fibroblasts, about five dysfunctional short telomeres are required to trigger senescence.
“For human fibroblasts, a threshold of five dysfunctional short telomeres seems to be needed to trigger a senescence response in vitro50.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [50] Kaul, Z., Cesare, A. J., Huschtscha, L. I., Neumann, A. A. & Reddel, R. R. Five dysfunctional telomeres predict onset of senescence in human cells. EMBO Rep. 13, 52–59 (2011). source
Not checked in the free run.
- Premisecitation
In mice, deletion of Cdkn1a (encoding p21) partially rescues the HSC self-renewal defect caused by telomere dysfunction.
“but deletion of cyclin-dependent kinase inhibitor 1a (Cdkn1a), which encodes p21, a transcriptional target of p53, partially rescues the HSC self-renewal defect in mice118.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [118] Choudhury, A. R. et al. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nature Genet. 39, 99–105 (2007). source
Not checked in the free run.
- Interpretationreasoning
The telomere-related stem cell failure state is primarily cell-autonomous.
“In humans, the aplastic anaemia phenotype can be reversed with allogeneic stem cell transplant, indicating that this telomere-related stem cell failure state is primarily cell-autonomous.”
Quote in the paperNot a substantial claim- Rests on an assumption: Allogeneic stem cell transplantation can reverse aplastic anaemia in humans.
- Premisecitation
Even when one disorder's symptoms dominate, affected people often have subclinical disease in other organs at the same time.
“However, affected individuals often have subclinical disease concurrently in other organs, even when symptoms related to a single disorder predominate13,39.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Not checked in the free run.
- cites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
Not checked in the free run.
- Interpretationreasoning
Telomere syndromes are probably the most common monogenic disorders of premature ageing.
“Moreover, as we will discuss, they probably represent the most prevalent monogenic premature ageing disorders.”
Quote in the paperNot a substantial claim - Premisecitation
Human male germ cells maintain stable telomere lengths or even lengthen them with age.
“In human male germ cells, telomere lengths remain stable or even elongate with age3.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Allsopp, R. C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl Acad. Sci. USA 89, 10114–10118 (1992). References 2 and 3 showed that telomere length shortens in human cells with age and limits their in vitro replicative potential. source
Not checked in the free run.
- Premisecitation
In mice, the telomere defect alone is not sufficient to induce spontaneous lung disease.
“Moreover, the telomere defect alone is not sufficient to induce spontaneous lung disease in mice99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- Premisecitation
In murine alveolar epithelial cells, cell turnover is very slow, about 2% per week.
“In contrast to the bone marrow, in the lung, cell turnover is very slow (2% per week in murine alveolar epithelial cells)99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- Premisecitation
Mouse and yeast studies indicate that cell responses are determined by the shortest telomeres rather than by average telomere length.
“Studies in mice and yeast have shown that it is not the average but the shortest telomeres that determine cell responses, suggesting that only one, or a few, overtly short telomeres trigger the DNA damage response and the consequent checkpoint cascade34,48,49.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [34] Teixeira, M. T., Arneric, M., Sperisen, P. & Lingner, J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 117, 323–335 (2004). source
Not checked in the free run.
- cites [48] Hemann, M. T., Strong, M. A., Hao, L. Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67–77 (2001). This study established that the shortest telomeres have a genetically dominant influence on cellular phenotypes. source
Not checked in the free run.
- cites [49] McEachern, M. J. & Blackburn, E. H. Cap-prevented recombination between terminal telomeric repeat arrays (telomere CPR) maintains telomeres in Kluyveromyces lactis lacking telomerase. Genes Dev. 10, 1822–1834 (1996). source
Not checked in the free run.
- Premisecitation
Tissues with rapid cell turnover are especially sensitive to telomere length.
“Although it was initially clear that high-turnover tissues are particularly sensitive to telomere length85,101,112”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [85] Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998). References 84 and 85 are two landmark papers that established that telomerase itself is not essential and that short telomeres cause apoptosis and cell loss in high-turnover tissues. source
Not checked in the free run.
- cites [101] Rudolph, K. L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701–712 (1999). source
Not checked in the free run.
- cites [112] Herrera, E. et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950–2960 (1999). source
Not checked in the free run.
- Premisecitation
In humans and mice, short telomeres cause quantitative and qualitative defects in hematopoietic stem cells, manifesting as stem cell exhaustion.
“In both humans and mice, there is clear evidence that short telomeres cause quantitative and qualitative defects in HSCs, which manifest as stem cell exhaustion36,41,71,114–117 (Fig. 4).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
Not checked in the free run.
- cites [41] Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413–1424 (2005). This study identified TERT mutations in patients with aplastic anaemia. source
Not checked in the free run.
- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
- Interpretationcitation
The constitutional telomere length in humans and mice is probably established early in embryonic development, during a transient increase in telomerase activity.
“The constitutional telomere length in humans and mice is likely to be set early in embryonic development, when telomerase activity is transiently upregulated44.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [44] Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W. & Shay, J. W. Telomerase activity in human germline and embryonic tissues and cells. Dev. Genet. 18, 173–179 (1996). source
Not checked in the free run.
- Premisecitation
IPF patients with telomerase mutations face a higher risk of bone marrow failure and liver disease.
“For example, patients with IPF who have mutant telomerase genes are at an increased risk of developing bone marrow failure and liver disease54,71.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [54] Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105, 13051–13056 (2008). source
Not checked in the free run.
- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
- Premisecitation
People with telomere-related aplastic anaemia are more likely to develop fatal pulmonary fibrosis if they receive pulmonary toxic drugs during bone marrow transplantation.
“Conversely, individuals with telomere-related aplastic anaemia have an increased incidence of fatal pulmonary fibrosis when they are exposed to pulmonary toxic drugs in the bone marrow transplant setting, even though they may have previously had no symptoms58,71.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [58] de la Fuente, J. & Dokal, I. Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation. Pediatr. Transplant 11, 584–594 (2007). source
Not checked in the free run.
- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
- Premisecitation
In mice, short telomeres reduce the threshold for disease from additional external or internal insults, including γ-irradiation and ER stress from misfolded proteins.
“Indeed, in mouse models, short telomeres have been shown to lower the disease threshold to other exogenous and endogeneous damage, such as γ-irradiation119 and endoplasmic reticulum stress due to protein misfolding97 (Fig. 5a).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [119] Wong, K. K. et al. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nature Genet. 26, 85–88 (2000). source
Not checked in the free run.
- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
- Interpretationcitation
In this context, smoking adds damage to already dysfunctional telomeres in lung epithelial cells.
“In this setting, the cigarette smoke causes additive damage to dysfunctional telomeres in lung epithelial cells.”
Quote in the paperSubstantial claim - Premisecitation
Mice with short telomeres show altered secretory profiles in their serum.
“Differential secretory profiles have also been detected in sera from mice with short telomeres121.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] Jiang, H. et al. Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease. Proc. Natl Acad. Sci. USA 105, 11299–11304 (2008). source
Not checked in the free run.
- Interpretationreasoning
The cumulative effect of cigarette smoke and dysfunctional telomeres likely reaches a threshold of cellular damage that develops into emphysema.
“The cumulative effect is likely to reach a threshold of cellular damage that develops into an airspace destruction phenotype recognized as emphysema.”
Quote in the paperSubstantial claim - Premisecitation
In these tissues, reduced PGC1α, a co-activator needed for mitochondrial biogenesis, seems to explain the metabolic defect.
“In these tissues, the metabolic dysfunction appears to be due to the effect of downregulation of PGC1α, which is a transcriptional co-activator that is important for mitochondrial biogenesis103.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [103] Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359–365 (2011). References 97 and 103 implicate short telomeres as a cause of mitochondrial dysfunction, a pathogenic mechanism that highlights a role for telomere dysfunction in slow-turnover tissues. source
Not checked in the free run.
- Interpretationreasoning
Dysfunctional telomeres in epithelial cells, or possibly other cells, could drive remodelling of parenchymal organs, appearing as fibrosis or emphysema.
“Therefore, telomere dysfunction in epithelial cells, or perhaps another cell type, might cause parenchymal organ remodelling, which manifests as fibrosis and/or emphysema46,54,99.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [46] Zhou, J., Monson, E. K., Teng, S. C., Schulz, V. P. & Zakian, V. A. Pif1p helicase, a catalytic inhibitor of telomerase in yeast. Science 289, 771–774 (2000). source
Not checked in the free run.
- cites [54] Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105, 13051–13056 (2008). source
Not checked in the free run.
- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- Premisecitation
In other mouse cells, including cardiac myocytes and hepatocytes, short dysfunctional telomeres correlate with fewer mitochondrial copies and impaired oxidative metabolism.
“Shortened dysfunctional telomeres in other mouse cell types, such as cardiac myocytes and hepatocytes, have also been associated with decreased mitochondrial copy number and defective oxidative metabolism103.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103] Sahin, E. et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 470, 359–365 (2011). References 97 and 103 implicate short telomeres as a cause of mitochondrial dysfunction, a pathogenic mechanism that highlights a role for telomere dysfunction in slow-turnover tissues. source
Not checked in the free run.
- Interpretationreasoning
These extra phenotypes bring telomere-related disease into the clinical arena of common conditions like IPF and diabetes.
“These additional phenotypes now extend the scope of telomere-mediated disease into clinical contexts of prevalent conditions, such as IPF and diabetes.”
Quote in the paperSubstantial claim - Premisecitation
In adult mouse β-cells, short telomeres produce spontaneous defects in insulin secretion both in vivo and in vitro, despite preserved β-cell mass.
“Short telomeres cause spontaneous insulin secretion defects in vivo and in vitro, even when the β-cell mass is intact97 (Fig. 5b).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
- Premisecitation
Certain senescence types, among them telomere-driven replicative senescence, show an in vitro secretory phenotype in which cytokines and proteases appear in culture medium.
“Indeed, some types of cellular senescence, including the telomere-induced replicative type, are associated with an in vitro senescence-associated secretory phenotype (SASP), where cytokines and proteases are detected in culture media120.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [120] Coppe, J. P., Desprez, P. Y., Krtolica, A. & Campisi, J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99–118 (2010). source
Not checked in the free run.
- Premisecitation
Altered gene expression in these cells disrupts pathways needed for insulin secretion signalling and exocytosis, such as mitochondrial function and calcium handling.
“The dysregulation of gene expression affects pathways that are essential for insulin secretion signalling and exocytosis, including mitochondrial function and Ca2+ handling97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
- Premisecitation
Fibroblasts undergoing replicative senescence in vitro also show gene expression changes caused by telomere shortening.
“Gene expression changes due to telomere shortening also occur in vitro in fibroblasts undergoing replicative senescence122.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] Zhang, H., Pan, K. H. & Cohen, S. N. Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc. Natl Acad. Sci. USA 100, 3251–3256 (2003). source
Not checked in the free run.
- Interpretationcitation
Under certain conditions, shortened dysfunctional telomeres can impair organ function while cell numbers remain intact.
“Although telomere dysfunction causes obvious histopathology in the bone marrow and parenchymal organs, there is evidence that in some settings, short dysfunctional telomeres compromise organ homeostasis even when cell mass is preserved.”
Quote in the paperSubstantial claim - Interpretationreasoning
A second hit may be needed in the lung because its baseline proliferation is so slow that replicative exhaustion is delayed.
“The requirement for a ‘second hit’ in the lung may be related to the fact that its basal proliferation rate is very slow, and therefore replicative exhaustion is delayed.”
Quote in the paperSubstantial claim - Premisecitation
In early stages of human age-related diabetes, insulin secretion is impaired despite intact β-cell mass.
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [123] Prentki, M. & Nolan, C. J. Islet β cell failure in type 2 diabetes. J. Clin. Invest. 116, 1802–1812 (2006). source
Not checked in the free run.
- Premisecitation
In mice with short telomeres, experimental exposure to cigarette smoke causes lung disease.
“Instead, a second insult is required, and when mice with short telomeres are experimentally exposed to cigarette smoke, which is known to accelerate disease onset in human telomerase mutation carriers, they develop lung disease99.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- Rests on an assumption: Smoking hastens disease onset in people who carry telomerase mutations.
- Interpretationreasoning
If slow-turnover tissues need several extra hits before phenotypes appear, this could account for telomere-related lung disease being mild, adult-onset, and usually diagnosed after midlife.
“A model that requires multiple additional hits for phenotypes to manifest in slow-turnover tissues could explain why telomere-mediated lung disease represents an attenuated, adult-onset phenotype that is commonly seen after middle age12,99.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [12] Armanios, M. Telomerase and idiopathic pulmonary fibrosis. Mutat. Res. 730, 52–58 (2012). source
Not checked in the free run.
- cites [99] Alder, J. K. et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 183, 904–912 (2011). source
Not checked in the free run.
- May combine two claims. 23
May combine two claims.
PremisecitationBecause losing function of a single TERT or TR allele is enough to impair telomere maintenance, these mutations follow autosomal-dominant inheritance.
“They manifest in an autosomal-dominant inheritance pattern because complete or partial loss-of-function of one allele is sufficient to perturb telomere maintenance38,39,41.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [38] Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001). source
Not checked in the free run.
- cites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
Not checked in the free run.
- cites [41] Yamaguchi, H. et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352, 1413–1424 (2005). This study identified TERT mutations in patients with aplastic anaemia. source
Not checked in the free run.
May combine two claims.
PremisecitationHuman population and twin studies indicate that parental telomere length, especially paternal, affects offspring telomere length, with heritability estimates between 0.36 and 0.84.
“In addition to studies in families, a number of population-based twin and non-twin studies have shown that parental telomere length (especially the paternal) influences offspring telomere length with heritability estimates ranging from 0.36–0.84 (reviewed in Ref. 90).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [90] Aviv, A. Genetics of leukocyte telomere length and its role in atherosclerosis. Mutat. Res. 730, 68–74 (2012). source
Not checked in the free run.
May combine two claims.
PremisereasoningMouse studies show that telomere length is inherited as a distinct genotype and can be uncoupled from the telomerase and telomere gene loci.
“When quantified, telomere length is short in wild-type offspring of parent M. castaneus mice that have short telomeres, indicating that telomere length is inherited36,82”
- Also stated in: § Evidence from mouse studies · plain
“Therefore, telomere length is inherited as a unique genotype, and its inheritance can be uncoupled from the telomerase and telomere gene loci.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [36] Hao, L. Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121–1131 (2005). In reference 36, using CAST/EiJ mice that have telomere length similar to humans, this paper established that telomerase haploinsufficiency is sufficient to cause dyskeratosis-congenita-like phenotypes. It also showed that telomere length is inherited and can cause degenerative phenotypes even when telomerase is wild-type. source
Not checked in the free run.
- cites [82] Armanios, M. et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 85, 823–832 (2009). source
Not checked in the free run.
- Also stated in: § Evidence from mouse studies · plain
May combine two claims.
PremisecitationIn autosomal-dominant telomere syndrome families, pulmonary fibrosis typically appears in earlier generations, while bone marrow failure becomes the first complication in later generations.
“In earlier generations, pulmonary fibrosis is usually the primary manifestation, whereas in later generations, bone marrow failure in younger individuals is seen as a first complication71.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationMost telomere disorders appear in adulthood and result from inherited loss-of-function mutations in TERT or TR.
“Telomere disorders most commonly manifest as adult-onset disease and as a consequence of germline TERT or TR loss-of-function mutations13.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Not checked in the free run.
May combine two claims.
PremisecitationSignalling from short telomeres activates checkpoints that cause either senescence or apoptosis, and sometimes both at once.
“The consequent signalling cascades activate checkpoints that induce either cellular senescence or apoptosis, and in at least some contexts both processes occur simultaneously82,85,91,95.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [82] Armanios, M. et al. Short telomeres are sufficient to cause the degenerative defects associated with aging. Am. J. Hum. Genet. 85, 823–832 (2009). source
Not checked in the free run.
- cites [85] Lee, H. W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998). References 84 and 85 are two landmark papers that established that telomerase itself is not essential and that short telomeres cause apoptosis and cell loss in high-turnover tissues. source
Not checked in the free run.
- cites [91] d'Adda di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194–198 (2003). source
Not checked in the free run.
- cites [95] Hemann, M. T. et al. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12, 2023–2030 (2001). source
Not checked in the free run.
May combine two claims.
PremisecitationOnly about one tenth of dyskeratosis congenita cases die from cancer; the rest die from degenerative phenotypes.
“However, the cancer-related mortality is limited to approximately 10% of dyskeratosis congenita cases, with the remaining mortality attributable to the degenerative disease phenotypes described above.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTERT or TR mutations are found in 8-15% of familial IPF and 1-3% of sporadic IPF cases.
“The frequency of these mutations is highest in individuals with the progressive disorder IPF, which accounts for 8–15% of familial and 1–3% of sporadic cases54,56,68,69.”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [54] Alder, J. K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 105, 13051–13056 (2008). source
Not checked in the free run.
- cites [56] Armanios, M. Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007). References 54–56 showed that lymphocyte telomere length using flow cytometry and fluorescence in situ hybridization could be a useful diagnostic marker in identifying individuals with telomere-related disease. source
Not checked in the free run.
- cites [68] Tsakiri, K. D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl Acad. Sci. USA 104, 7552–7557 (2007). References 56 and 68 identified mutations in the essential telomerase genes in familial pulmonary fibrosis. source
Not checked in the free run.
- cites [69] Cronkhite, J.T. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178, 729–737 (2008). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningHow short telomeres become determines both how severe the disease is and which disease type appears.
“Hence, the degree of telomere shortness is a determinant of both disease severity and type.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTelomere-induced senescence acts mainly through p53-dependent pathways, though the RB pathway may also be involved in some contexts.
“The downstream effector pathways of telomere-induced senescence are largely p53-dependent96, but there may be involvement of the retinoblastoma protein (RB) pathway in some settings97.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [96] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999). source
Not checked in the free run.
- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
May combine two claims.
PremisecitationEight genes have been found mutated in dyskeratosis congenita, and every one encodes a telomerase or telomere protein component.
“Eight mutant genes have been identified in dyskeratosis congenita9,38,39,60–64, and all of them encode telomerase or telomere protein components (summarized in Table 1).”
Quote in the paperNot a substantial claim0 of 8 sources checked- cites [9] Heiss, N. S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genet. 19, 32–38 (1998). This study identified mutations in the X-linked DKC1 gene as a first cause of dyskeratosis congenita. source
Not checked in the free run.
- cites [38] Vulliamy, T. et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432–435 (2001). source
Not checked in the free run.
- cites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
Not checked in the free run.
- cites [60] Vulliamy, T. et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Natl Acad. Sci. USA 105, 8073–8078 (2008). source
Not checked in the free run.
- cites [61] Walne, A. J. et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum. Mol. Genet. 16, 1619–1629 (2007). source
Not checked in the free run.
- cites [62] Savage, S. A. et al. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am. J. Hum. Genet. 82, 501–509 (2008). This paper was the first to show that mutations in a shelterin component are a cause of dyskeratosis congenita. source
Not checked in the free run.
- cites [63] Zhong, F. et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 25, 11–16. source
Not checked in the free run.
- cites [64] Keller, R. B. et al. CTC1 mutations in a patient with dyskeratosis congenita. Pediatr. Blood Cancer 59, 311–314 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationMean leukocyte telomere length is a surrogate for the mean in a mixed cell population, and telomere length is mosaic across cell types.
“When examining telomere measurements within a mixed cell population, it is important to note that this is a surrogate marker of the mean in a heterogeneous cell population and that telomere length is mosaic, reflecting the telomere length regulation and replicative history of each cell type51,52.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [51] Lin, J. et al. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J. Immunol. Methods 352, 71–80 (2010). source
Not checked in the free run.
- cites [52] Rufer, N. et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J. Exp. Med. 190, 157–167 (1999). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause telomerase synthesis on human telomeres is limited, telomere shortening is the default state and generally accompanies cell proliferation.
“The limitation on the telomerase synthesis reaction on human telomeres favours telomere shortening as a general default state and means that telomere shortening generally accompanies cell proliferation.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMost human cancers have increased telomerase activity, which probably helps them maintain immortality.
“This idea is consistent with the fact that telomerase activity is upregulated in most human cancers, which probably contributes to sustaining their immortality7.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [7] Kim, N. W. et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011–2015 (1994). In this study, telomerase activity was found to be enriched in cancer and germ cells, suggesting that telomerase has a role in extending replicative potential. source
Not checked in the free run.
May combine two claims.
Interpretationnone givenBecause the shared short telomere defect is acquired with age, telomere syndromes are highly relevant to understanding age-related disease.
“The telomere syndromes are highly relevant for understanding age-related disease because the short telomere defect that they share is acquired with age.”
Quote in the paperNot a substantial claim- Rests on an assumption: The short telomere defect shared by telomere syndromes is acquired with age.
May combine two claims.
InterpretationreasoningThe common telomere defect underlying aplastic anaemia and IPF unites previously separate clinical entities into a recognizable syndrome complex that mainly appears in adults.
“The shared underlying telomere defect in aplastic anaemia and IPF brings together clinical entities that were previously considered to be disparate and defines a recognizable syndrome complex that predominantly manifests in adults, in contrast to dyskeratosis congenita.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationTelomerase adds telomere repeats during S phase and into M phase, so elongation is cell-cycle-regulated.
“Telomere elongation is cell-cycle-regulated; telomerase elongates telomeric DNA by adding telomere repeats during S phase and into M phase32,33.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [32] Diede, S. J. & Gottschling, D. E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases α and δ. Cell 99, 723–733 (1999). source
Not checked in the free run.
- cites [33] Marcand, S., Brevet, V., Mann, C. & Gilson, E. Cell cycle restriction of telomere elongation. Curr. Biol. 10, 487–490 (2000). source
Not checked in the free run.
May combine two claims.
InterpretationcitationWhen IPF, bone marrow failure, and liver cirrhosis occur together, this combination is specific for and strongly predicts an inherited telomere maintenance defect.
“Indeed, the co-occurrence of IPF and bone marrow failure, along with liver cirrhosis, is specific to and highly predictive of a germline telomere maintenance defect13,39,71.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [13] Armanios, M. Syndromes of telomere shortening. Annu. Rev. Genom. Hum. Genet. 10, 45–61 (2009). source
Not checked in the free run.
- cites [39] Armanios, M. et al. Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc. Natl Acad. Sci. USA 102, 15960–15964 (2005). References 38 and 39 identified mutations in the essential telomerase genes, TERT and TR , in dyskeratosis congenita. source
Not checked in the free run.
- cites [71] Parry, E. M., Alder, J. K., Qi, X., Chen, J. J. & Armanios, M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood 117, 5607–5611 (2011). source
Not checked in the free run.
May combine two claims.
InterpretationcitationSenescence caused by telomere dysfunction is not merely loss of replicative capacity; it can impair cell function while cells still look normal.
“Therefore, it seems that telomere-induced senescence represents more than a loss of replicative potential and can limit cellular function even when cells appear morphologically intact97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
May combine two claims.
Interpretationnone givenTelomere syndromes are a model example of premature ageing because their shared short-telomere defect accumulates with age in people.
“Telomere syndromes represent an archetype of premature-ageing syndromes because the short telomere defect they share is progressively acquired with age in humans.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIn addition to its classic effects in high-turnover tissues, telomere dysfunction can by itself produce, and often does produce, degenerative changes in slow-turnover tissues.
“Beyond its canonical phenotypes in high-turnover tissues, telomere dysfunction is sufficient to cause — and indeed commonly causes — degenerative phenotypes in slow-turnover tissues.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAlthough they look normal, mouse β-cells carrying dysfunctional telomeres display senescence features: DNA damage response activation, reduced proliferation, increased p16INK4A, and changed gene expression.
“Although they appear morphologically normal, mouse β-cells with dysfunctional telomeres show the hallmarks of senescence. They have an activated DNA damage response, impaired proliferation, p16INK4A upregulation and altered gene expression97.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [97] Guo, N. et al. Short telomeres compromise β-cell signaling and survival. PLoS ONE 6, e17858 (2011). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningBecause telomere-driven senescence alters gene expression and thereby function without disrupting tissue structure, this reveals a new way senescence can cause disease.
“The fact that the gene expression changes that occur during telomere-induced senescence cause functional changes in the absence of structural tissue disruption highlights a novel mechanism by which senescence and its associated gene expression changes cause disease.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The short telomere defect shared by telomere syndromes is acquired with age.
“The telomere syndromes are highly relevant for understanding age-related disease because the short telomere defect that they share is acquired with age.”
The paper relies on this without support.
The short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.
“Their grouping together as a syndrome spectrum is crucial for clinical decisions because the short telomere defect in affected individuals is present in germ cells and thus simultaneously affects multiple organs even when one disease presentation predominates.”
The paper relies on this without support.
Allogeneic stem cell transplantation can reverse aplastic anaemia in humans.
“In humans, the aplastic anaemia phenotype can be reversed with allogeneic stem cell transplant, indicating that this telomere-related stem cell failure state is primarily cell-autonomous.”
The paper relies on this without support.
Smoking hastens disease onset in people who carry telomerase mutations.
“Instead, a second insult is required, and when mice with short telomeres are experimentally exposed to cigarette smoke, which is known to accelerate disease onset in human telomerase mutation carriers, they develop lung disease99.”
The paper relies on this without support.
β-cells in adult mouse pancreatic islets turn over slowly, roughly 4% each week.
“This mechanism has been elucidated in adult mouse β-cells of the pancreatic islets, which have a fairly slow turnover (4% per week).”
The paper relies on this without support.
Blood formation depends on a small set of stem cells that can self-renew and differentiate.
“Haematopoiesis relies on the self-renewal and differentiation capacity of a well-characterized oligoclonal stem cell compartment.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Progerias or premature aging, or the short telomere syndromes, include genetic diseases associated with short telomeres and premature senescence.
“Progerias or premature aging, or the short telomere syndromes include genetic diseases associated with short telomeres and premature senescence [59].”
From Markers of cellular senescence. Telomere shortening as a marker of cellular senescence (2016) · cites this paper as [59]
Rare Mendelian human mutations compromising telomere maintenance or protection genes cause early death and diseases involving a wide variety of tissues and organ systems.
“Rare Mendelian human mutations compromising telomere maintenance or protection genes cause early death and diseases involving a wide variety of tissues and organ systems (Armanios and Blackburn, 2012).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
The ribonucleoprotein enzyme telomerase provides the major mechanism for telomere preservation and length replenishment.
“The ribonucleoprotein enzyme telomerase provides the major mechanism for telomere preservation and length replenishment (Armanios and Blackburn, 2012; Chakhparonian and Wellinger, 2003) (Fig 1).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
Inherited telomerase deficiencies resulting in a two-fold drop in gene dosage are directly linked to malignancies and several other diseases in humans.
“Inherited telomerase deficiencies resulting in a two-fold drop in gene dosage are directly linked to malignancies and several other diseases in humans (Armanios and Blackburn, 2012).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Armanios and Blackburn, 2012
Short telomeres have been linked to numerous diseases of aging and, in many but not all cases, to all-cause and disease-specific mortality.
“Short telomeres have been linked to numerous diseases of aging and in many but not all cases, to all-cause and disease-specific mortality (12–17).”
From Determinants of telomere attrition over 1 year in healthy older women: stress and health behaviors matter (2015) · cites this paper as [12]
Stress appears to augment replicative telomere shortening.
“stress appears to augment replicative TL shortening, perhaps by promoting nonenzymatic hydrolysis of telomere base pairs (11,18).”
From Social disadvantage, genetic sensitivity, and children's telomere length (2014) · cites this paper as [18]
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091 · see citing works
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · see citing works
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · see citing works
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400 · see citing works
Self-citationShelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · see citing works
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,855 · see citing works
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,359 · see citing works
Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M. A. C., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., & Wu, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6622 · Cited by 2,326 · see citing works
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · see citing works
Telomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200 · see citing works
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108 · see citing works
How Shelterin Protects Mammalian Telomeres
Palm, W., & de Lange, T. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.41.110306.130350 · Cited by 1,802 · see citing works
Islet cell failure in type 2 diabetes
Prentki, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29103 · Cited by 1,690 · see citing works
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643 · see citing works
Self-citationTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357 · see citing works
Self-citationLongevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice
Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80580-2 · Cited by 1,349 · see citing works
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319 · see citing works
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · see citing works
Reverse Transcriptase Motifs in the Catalytic Subunit of Telomerase
Lingner, J., Hughes, T. R., Shevchenko, A., Mann, M., Lundblad, V., & Cech, T. R. (1997) · Science · doi:10.1126/science.276.5312.561 · Cited by 1,269 · see citing works
Hemann, M. T., Strong, M. A., Hao, L.-Y., & Greider, C. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00504-9 · Cited by 1,219 · see citing works
A telomerase component is defective in the human disease dyskeratosis congenita
Mitchell, J. R., Wood, E., & Collins, K. (1999) · Nature · doi:10.1038/990141 · Cited by 1,168 · see citing works
Greider, C. W., & Blackburn, E. H. (1987) · Cell · doi:10.1016/0092-8674(87)90576-9 · Cited by 1,150 · see citing works
Self-citationEvidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age.
Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9857 · Cited by 1,132 · see citing works
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age
Rossi, D. J., Bryder, D., Seita, J., Nussenzweig, A., Hoeijmakers, J., & Weissman, I. L. (2007) · Nature · doi:10.1038/nature05862 · Cited by 1,115 · see citing works
Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging
Blackburn, E. H., Greider, C. W., & Szostak, J. W. (2006) · Nature Medicine · doi:10.1038/nm1006-1133 · Cited by 992 · see citing works
Self-citationChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979 · see citing works
Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., & Dokal, I. (1998) · Nature Genetics · doi:10.1038/ng0598-32 · Cited by 976 · see citing works
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · see citing works
Adult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894 · see citing works
A crucial role for adipose tissue p53 in the regulation of insulin resistance
Minamino, T., Orimo, M., Shimizu, I., Kunieda, T., Yokoyama, M., Ito, T., Nojima, A., Nabetani, A., Oike, Y., Matsubara, H., et al. (2009) · Nature Medicine · doi:10.1038/nm.2014 · Cited by 891 · see citing works
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823 · see citing works
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Alder, J. K., Chen, J. J.-L., Lancaster, L., Danoff, S., Su, S.-C., Cogan, J. D., Vulto, I., Xie, M., Qi, X., Tuder, R. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804280105 · Cited by 805 · see citing works
Self-citationLoss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.
Vaziri, H., Schächter, F., Uchida, I. A., Wei, L., Zhu, X., Effros, R. B., Cohen, D., & Harley, C. (1993) · PubMed · Cited by 734 · see citing works
Mutations in <i>TERT,</i> the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723 · see citing works
Rufer, N., Brümmendorf, T. H., Kolvraa, S., Bischoff, C., Christensen, K., Wadsworth, L., Schulzer, M., & Lansdorp, P. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.157 · Cited by 709 · see citing works
Secondary Structure of Vertebrate Telomerase RNA
Chen, J.-L., Blasco, M. A., & Greider, C. W. (2000) · Cell · doi:10.1016/s0092-8674(00)80687-x · Cited by 605 · see citing works
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
Cronkhite, J. T., Xing, C., Raghu, G., Chin, K. M., Torres, F., Rosenblatt, R. L., & Kim Garcia, C. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200804-550oc · Cited by 573 · see citing works
Teixeira, M. T., Arneric, M., Sperisen, P., & Lingner, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00334-4 · Cited by 526 · see citing works
A Human Telomerase Holoenzyme Protein Required for Cajal Body Localization and Telomere Synthesis
Venteicher, A. S., Abreu, E. B., Meng, Z., McCann, K. E., Terns, R. M., Veenstra, T. D., Terns, M. P., & Artandi, S. E. (2009) · Science · doi:10.1126/science.1165357 · Cited by 522 · see citing works
Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512 · see citing works
A Box H/ACA Small Nucleolar RNA-Like Domain at the Human Telomerase RNA 3′ End
Mitchell, J. R., Cheng, J., & Collins, K. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.567 · Cited by 510 · see citing works
Cancer in dyskeratosis congenita
Alter, B. P., Giri, N., Savage, S. A., & Rosenberg, P. S. (2009) · Blood · doi:10.1182/blood-2008-12-192880 · Cited by 478 · see citing works
Disease states associated with telomerase deficiency appear earlier in mice with short telomeres
Herrera, E., Samper, E., Martín‐Caballero, J., Flores, J. M., Lee, H., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.2950 · Cited by 471 · see citing works
Essential role of limiting telomeres in the pathogenesis of Werner syndrome
Chang, S., Multani, A. S., Cabrera, N. G., Naylor, M. L., Laud, P., Lombard, D., Pathak, S., Guarente, L., & DePinho, R. A. (2004) · Nature Genetics · doi:10.1038/ng1389 · Cited by 462 · see citing works
Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I. (2004) · Nature Genetics · doi:10.1038/ng1346 · Cited by 461 · see citing works
Armanios, M., Chen, J.-L., Chang, Y.-P. C., Brodsky, R. A., Hawkins, A., Griffin, C. A., Eshleman, J. R., Cohen, A. R., Chakravarti, A., Hamosh, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508124102 · Cited by 452 · see citing works
Self-citationFlow cytometry and FISH to measure the average length of telomeres (flow FISH)
Baerlocher, G. M., Vulto, I., de Jong, G., & Lansdorp, P. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.263 · Cited by 449 · see citing works
Choudhury, A. R., Ju, Z., Djojosubroto, M. W., Schienke, A., Lechel, A., Schaetzlein, S., Jiang, H., Stepczynska, A., Wang, C., Buer, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1937 · Cited by 426 · see citing works
Lin, J., Epel, E., Cheon, J., Kroenke, C., Sinclair, E., Bigos, M., Wolkowitz, O., Mellon, S., & Blackburn, E. (2010) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.09.012 · Cited by 426 · see citing works
Self-citationInhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424 · see citing works
Savage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · see citing works
Telomere dysfunction and tumour suppression: the senescence connection
Deng, Y., Chan, S. S., & Chang, S. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2393 · Cited by 411 · see citing works
Chiu, C., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1996) · STEM CELLS · doi:10.1002/stem.140239 · Cited by 388 · see citing works
Telomerase-Mediated Telomere Addition In Vivo Requires DNA Primase and DNA Polymerases α and δ
Diede, S. J., & Gottschling, D. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81670-0 · Cited by 379 · see citing works
Telomere Lengths, Pulmonary Fibrosis and Telomerase (TERT) Mutations
Diaz de Leon, A., Cronkhite, J. T., Katzenstein, A.-L. A., Godwin, J. D., Raghu, G., Glazer, C. S., Rosenblatt, R. L., Girod, C. E., Garrity, E. R., Xing, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010680 · Cited by 377 · see citing works
Alter, B. P., Baerlocher, G. M., Savage, S. A., Chanock, S. J., Weksler, B. B., Willner, J. P., Peters, J. A., Giri, N., & Lansdorp, P. M. (2007) · Blood · doi:10.1182/blood-2007-02-075598 · Cited by 356 · see citing works
Miyake, Y., Nakamura, M., Nabetani, A., Shimamura, S., Tamura, M., Yonehara, S., Saito, M., & Ishikawa, F. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.009 · Cited by 350 · see citing works
Aubert, G., Hills, M., & Lansdorp, P. M. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.04.003 · Cited by 342 · see citing works
Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., & Dokal, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800042105 · Cited by 334 · see citing works
Telomerase: An RNP Enzyme Synthesizes DNAPreprint
Blackburn, E. H., & Collins, K. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003558 · Cited by 333 · see citing works
Self-citationAllsopp, R. C., Morin, G. B., DePinho, R., Harley, C. B., & Weissman, I. L. (2003) · Blood · doi:10.1182/blood-2002-07-2334 · Cited by 324 · see citing works
Syndromes of Telomere Shortening
Armanios, M. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150046 · Cited by 317 · see citing works
Self-citationWalne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008) · Blood · doi:10.1182/blood-2008-05-153445 · Cited by 317 · see citing works
Walne, A. J., Vulliamy, T., Marrone, A., Beswick, R., Kirwan, M., Masunari, Y., Al-Qurashi, F.-H., Aljurf, M., & Dokal, I. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm111 · Cited by 316 · see citing works
Leri, A., Franco, S., Zacheo, A., Barlucchi, L., Chimenti, S., Limana, F., Nadal‐Ginard, B., Kajstura, J., Anversa, P., & Blasco, M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg013 · Cited by 313 · see citing works
Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation
Wong, K.-K., Chang, S., Weiler, S. R., Ganesan, S., Chaudhuri, J., Zhu, C., Artandi, S. E., Rudolph, K. L., Gottlieb, G. J., Chin, L., et al. (2000) · Nature Genetics · doi:10.1038/79232 · Cited by 309 · see citing works
Short Telomeres, even in the Presence of Telomerase, Limit Tissue Renewal Capacity
Hao, L.-Y., Armanios, M., Strong, M. A., Karim, B., Feldser, D. M., Huso, D., & Greider, C. W. (2005) · Cell · doi:10.1016/j.cell.2005.11.020 · Cited by 302 · see citing works
Self-citationMutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome
Yamaguchi, H., Baerlocher, G. M., Lansdorp, P. M., Chanock, S. J., Nunez, O., Sloand, E., & Young, N. S. (2003) · Blood · doi:10.1182/blood-2003-01-0335 · Cited by 301 · see citing works
Surovtseva, Y. V., Churikov, D., Boltz, K. A., Song, X., Lamb, J. C., Warrington, R. T., Leehy, K. A., Heacock, M. L., Price, C. M., & Shippen, D. E. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.017 · Cited by 296 · see citing works
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus
Anderson, B., Kasher, P. R., Mayer, J., Szynkiewicz, M., Jenkinson, E. M., Bhaskar, S. S., Urquhart, J. E., Daly, S. B., Dickerson, J. E., O’Sullivan, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1084 · Cited by 284 · see citing works
Fogarty, P. F., Yamaguchi, H., Wiestner, A., Baerlocher, G. M., Sloand, E., Zeng, W. S., Read, E. J., Lansdorp, P. M., & Young, N. S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14797-6 · Cited by 277 · see citing works
Association between aplastic anaemia and mutations in telomerase RNA
Vulliamy, T., Marrone, A., Dokal, I. S., & Mason, P. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09087-6 · Cited by 276 · see citing works
The many facets of H/ACA ribonucleoproteins
Meier, U. T. (2005) · Chromosoma · doi:10.1007/s00412-005-0333-9 · Cited by 269 · see citing works
Telomere Length Is a Determinant of Emphysema Susceptibility
Alder, J. K., Guo, N., Kembou, F., Parry, E. M., Anderson, C. J., Gorgy, A. I., Walsh, M. F., Sussan, T., Biswal, S., Mitzner, W., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0520oc · Cited by 265 · see citing works
Self-citationDisruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita
Zhong, F., Savage, S. A., Shkreli, M., Giri, N., Jessop, L., Myers, T., Chen, R., Alter, B. P., & Artandi, S. E. (2011) · Genes & Development · doi:10.1101/gad.2006411 · Cited by 262 · see citing works
Savage, S. A., & Alter, B. P. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.003 · Cited by 262 · see citing works
Short Telomeres are Sufficient to Cause the Degenerative Defects Associated with Aging
Armanios, M., Alder, J. K., Parry, E. M., Karim, B., Strong, M. A., & Greider, C. W. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.10.028 · Cited by 257 · see citing works
Self-citationA Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations
Calado, R. T., Regal, J. A., Kleiner, D. E., Schrump, D. S., Peterson, N. R., Pons, V., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007926 · Cited by 252 · see citing works
Telomerase and idiopathic pulmonary fibrosis
Armanios, M. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.10.013 · Cited by 245 · see citing works
Self-citationCell cycle restriction of telomere elongation
Marcand, S., Brevet, V., Mann, C., & Gilson, E. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00450-4 · Cited by 240 · see citing works
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita
Alter, B. P., Rosenberg, P. S., Giri, N., Baerlocher, G. M., Lansdorp, P. M., & Savage, S. A. (2012) · Haematologica · doi:10.3324/haematol.2011.055269 · Cited by 238 · see citing works
Pif1p Helicase, a Catalytic Inhibitor of Telomerase in Yeast
Zhou, J.-Q., Monson, E. K., Teng, S.-C., Schulz, V. P., & Zakian, V. A. (2000) · Science · doi:10.1126/science.289.5480.771 · Cited by 236 · see citing works
Knight, S. W., Heiss, N. S., Vulliamy, T., Aalfs, C. M., McMahon, C., Richmond, P., Jones, A., Hennekam, R. C. M., Poustka, A., Mason, P. J., et al. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01690.x · Cited by 230 · see citing works
Wild-derived inbred mouse strains have short telomeres
Hemann, M. T. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.22.4474 · Cited by 227 · see citing works
Telomeres and Telomerase: The Means to the End (Nobel Lecture)
Blackburn, E. H. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002387 · Cited by 225 · see citing works
Self-citationFive dysfunctional telomeres predict onset of senescence in human cells
Kaul, Z., Cesare, A. J., Huschtscha, L. I., Neumann, A. A., & Reddel, R. R. (2012) · The EMBO Reports · doi:10.1038/embor.2011.227 · Cited by 225 · see citing works
McEachern, M. J., & Blackburn, E. H. (1996) · Genes & Development · doi:10.1101/gad.10.14.1822 · Cited by 224 · see citing works
Self-citationA Conserved WD40 Protein Binds the Cajal Body Localization Signal of scaRNP Particles
Tycowski, K. T., Shu, M.-D., Kukoyi, A., & Steitz, J. A. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.02.020 · Cited by 212 · see citing works
Zhang, H., Pan, K.-H., & Cohen, S. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627983100 · Cited by 209 · see citing works
Parry, E. M., Alder, J. K., Qi, X., Chen, J. J.-L., & Armanios, M. (2011) · Blood · doi:10.1182/blood-2010-11-322149 · Cited by 194 · see citing works
Self-citationConstitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia
Calado, R. T., Regal, J. A., Hills, M., Yewdell, W. T., Dalmazzo, L. F., Zago, M. A., Lansdorp, P. M., Hogge, D., Chanock, S. J., Estey, E. H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807057106 · Cited by 184 · see citing works
Telomeric repeat from T. thermophila cross hybridizes with human telomeres
Allshire, R. C., Gosden, J. R., Cross, S. H., Cranston, G., Rout, D., Sugawara, N., Szostak, J. W., Fantes, P. A., & Hastie, N. D. (1988) · Nature · doi:10.1038/332656a0 · Cited by 183 · see citing works
Short Telomeres Induce a DNA Damage Response in<i>Saccharomyces cerevisiae</i>
IJpma, A. S., & Greider, C. W. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.02-04-0057 · Cited by 178 · see citing works
Polvi, A., Linnankivi, T., Kivelä, T., Herva, R., Keating, J., Mäkitie, O., Pareyson, D., Vainionpää, L. K., Lahtinen, J., Hovatta, I., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.02.002 · Cited by 172 · see citing works
Jiang, H., Schiffer, E., Song, Z., Wang, J., Zürbig, P., Thedieck, K., Moes, S., Bantel, H., Saal, N., Jantos, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801457105 · Cited by 169 · see citing works
Evolution of CST function in telomere maintenance
Price, C. M., Boltz, K. A., Fedor‐Chaiken, M., Stewart, J. A., Beilstein, M. A., & Shippen, D. E. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12547 · Cited by 166 · see citing works
Gu, P., Min, J., Wang, Y., Huang, C., Peng, T., Chai, W., & Chang, S. S. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.96 · Cited by 162 · see citing works
Telomere Dysfunction Triggers Developmentally Regulated Germ Cell Apoptosis
Hemann, M. T., Rudolph, K. L., Strong, M. A., DePinho, R. A., Chin, L., & Greider, C. W. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.7.2023 · Cited by 162 · see citing works
Du, H.-Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R. T., Reiss, U. M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-166421 · Cited by 158 · see citing works
Is telomerase a viable target in cancer?
Buseman, C. M., Wright, W. E., & Shay, J. W. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.07.006 · Cited by 145 · see citing works
Impaired germinal center reaction in mice with short telomeres
Herrera, E., Martínez‐A, C., & Blasco, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.472 · Cited by 144 · see citing works
It all comes together at the ends: Telomerase structure, function, and biogenesis
Podlevsky, J. D., & Chen, J. J. ‐. (2011) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2011.11.002 · Cited by 144 · see citing works
Genetics of leukocyte telomere length and its role in atherosclerosis
Aviv, A. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.05.001 · Cited by 143 · see citing works
Defects in telomere maintenance molecules impair osteoblast differentiation and promote osteoporosis
Pignolo, R. J., Suda, R. K., McMillan, E. A., Shen, J., Lee, S., Choi, Y., Wright, A. C., & Johnson, F. B. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00350.x · Cited by 140 · see citing works
<i>CTC1</i> Mutations in a patient with dyskeratosis congenita
Keller, R. B., Gagne, K. E., Usmani, G. N., Asdourian, G. K., Williams, D. A., Hofmann, I., & Agarwal, S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24193 · Cited by 138 · see citing works
The molecular control of blood cells
Metcalf, D. (1988) · Cited by 137 · see citing works
Strong, M. A., Vidal-Cardenas, S. L., Karim, B. O., Yu, H. M., Guo, N., & Greider, C. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05312-11 · Cited by 134 · see citing works
Enomoto, S., Glowczewski, L., & Berman, J. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0012 · Cited by 133 · see citing works
Low abundance of telomerase in yeast: Implications for telomerase haploinsufficiency
Mozdy, A. D., & Cech, T. R. (2006) · RNA · doi:10.1261/rna.134706 · Cited by 123 · see citing works
De La Fuente, J., & Dokal, I. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00721.x · Cited by 119 · see citing works
Alder, J. K., Cogan, J. D., Brown, A. F., Anderson, C. J., Lawson, W. E., Lansdorp, P. M., Phillips, J. A., Loyd, J. E., Chen, J. J.-L., & Armanios, M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001352 · Cited by 119 · see citing works
Self-citationDNA damage signalling prevents deleterious telomere addition at DNA breaks
Makovets, S., & Blackburn, E. H. (2009) · Nature Cell Biology · doi:10.1038/ncb1985 · Cited by 112 · see citing works
Self-citationKirwan, M., Vulliamy, T., Marrone, A., Walne, A. J., Beswick, R., Hillmen, P., Kelly, R., Stewart, A., Bowen, D., Schonland, S. O., et al. (2009) · Human Mutation · doi:10.1002/humu.21115 · Cited by 109 · see citing works
Erdmann, N., Liu, Y., & Harrington, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401580101 · Cited by 107 · see citing works
The Molecular Control of Blood Cells
Noël, P. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65268-9 · Cited by 105 · see citing works
The effect of TERC haploinsufficiency on the inheritance of telomere length
Goldman, F., Bouarich, R., Kulkarni, S., FREEMAN, S., Du, H., Harrington, L. A., Mason, P. J., Londoño‐Vallejo, A., & Bessler, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505318102 · Cited by 105 · see citing works
Short Telomeres Compromise β-Cell Signaling and Survival
Guo, N., Parry, E. M., Li, L.-S., Kembou, F., Lauder, N., Hussain, M. A., Berggren, P.-O., & Armanios, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017858 · Cited by 100 · see citing works
Self-citationThe genome-wide expression response to telomerase deletion in <i>Saccharomyces</i> <i>cerevisiae</i>
Nautiyal, S., DeRisi, J. L., & Blackburn, E. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142162499 · Cited by 96 · see citing works
Self-citationJyonouchi, S. C., Forbes, L. R., Ruchelli, E. D., & Sullivan, K. E. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2010.01136.x · Cited by 95 · see citing works
Chiang, Y. J., Kim, S., Tessarollo, L., Campisi, J., & Hodes, R. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6631-6634.2004 · Cited by 86 · see citing works
Sznajer, Y., Baumann, C., David, A., Journel, H., Lacombe, D., Pérel, Y., Blouin, P., Segura, J., Cézard, J., Peuchmaur, M. M., et al. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1317-5 · Cited by 85 · see citing works
Knudson, M., Kulkarni, S., Ballas, Z. K., Bessler, M., & Goldman, F. (2005) · Blood · doi:10.1182/blood-2004-04-1673 · Cited by 82 · see citing works
Overlap of dyskeratosis congenita with the Hoyeraal-Hreidarsson syndrome
Yaghmai, R., Kimyai‐Asadi, A., Rostamiani, K., Heiss, N. S., Poustka, A., Eyaid, W., Bodurtha, J. N., Nousari, H. C., Hamosh, A., & Metzenberg, A. B. (2000) · The Journal of Pediatrics · doi:10.1067/mpd.2000.104295 · Cited by 75 · see citing works
Telomerase RNA Levels Limit the Telomere Length EquilibriumPreprint
Greider, C. W. (2006) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2006.71.063 · Cited by 56 · see citing works
Characterization of primitive hematopoietic cells from patients with dyskeratosis congenita
Goldman, F. D., Aubert, G., Klingelhutz, A. J., Hills, M., Cooper, S., Hamilton, W. S., Schlueter, A. J., Lambie, K., Eaves, C. J., & Lansdorp, P. M. (2008) · Blood · doi:10.1182/blood-2007-10-120204 · Cited by 54 · see citing works
T cell immunodeficiency in dyskeratosis congenita.
Lee, B. W., Yap, H., Quah, T. C., Chong, A. S., & Seah, C. C. (1992) · Archives of Disease in Childhood · doi:10.1136/adc.67.4.524 · Cited by 26 · see citing works
Makovets, S., Williams, T. L., & Blackburn, E. H. (2008) · Genetics · doi:10.1534/genetics.107.083030 · Cited by 21 · see citing works
Self-citationTelomerase activity in human germline and embryonic tissues and cells
Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., & Shay, J. W. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)18:2
Flagged first, then by citations
Cited by
Sorted by citations
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982 · see citing works
Senescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766 · see citing works
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596 · see citing works
Self-citationTelomeres and telomerase: three decades of progress
Shay, J. W., & Wright, W. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0099-1 · Cited by 924 · see citing works
Telomeres: history, health, and hallmarks of aging
Chakravarti, D., LaBella, K. A., & DePinho, R. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.028 · Cited by 637 · see citing works
The impact of oxidative DNA damage and stress on telomere homeostasis
Barnes, R. P., Fouquerel, E., & Opresko, P. L. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.03.013 · Cited by 558 · see citing works
Molecular and physiological manifestations and measurement of aging in humans
Khan, S. S., Singer, B. D., & Vaughan, D. E. (2017) · Aging Cell · doi:10.1111/acel.12601 · Cited by 530 · see citing works
Determinants of telomere length across human tissues
Demanelis, K., Jasmine, F., Chen, L. S., Chernoff, M., Tong, L., Delgado, D., Zhang, C., Shinkle, J., Sabarinathan, M., Lin, H., et al. (2020) · Science · doi:10.1126/science.aaz6876 · Cited by 515 · see citing works
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases
Haycock, P., Burgess, S., Nounu, A., Zheng, J., Okoli, G. N., Bowden, J., Wade, K. H., Timpson, N. J., Evans, D. M., Willeit, P., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5945 · Cited by 510 · see citing works
Clonal dynamics of haematopoiesis across the human lifespan
Mitchell, E., Chapman, M. S., Williams, N., Dawson, K. J., Mende, N., Calderbank, E. F., Jung, H., Mitchell, T. J., Coorens, T. H. H., Spencer, D. H., et al. (2022) · Nature · doi:10.1038/s41586-022-04786-y · Cited by 500 · see citing works
Markers of cellular senescence. Telomere shortening as a marker of cellular senescence
Bernadotte, A., Mikhelson, V. M., & Spivak, I. M. (2016) · Aging · doi:10.18632/aging.100871 · Cited by 466 · see citing works
Stress and telomere biology: a lifespan perspective
Shalev, I., Entringer, S., Wadhwa, P. D., Wolkowitz, O. M., Puterman, E., Lin, J., & Epel, E. S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.03.010 · Cited by 400 · see citing works
Polygenic basis and biomedical consequences of telomere length variation
Codd, V., Wang, Q., Allara, E., Musicha, C., Kaptoge, S. K., Stoma, S., Jiang, T., Hamby, S. E., Braund, P. S., Bountziouka, V. P., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00944-6 · Cited by 376 · see citing works
The roles of senescence and telomere shortening in cardiovascular disease
Fyhrquist, F., Saijonmaa, O. J., & Strandberg, T. E. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.30 · Cited by 368 · see citing works
Inverse Association of Telomere Length With Liver Disease and Mortality in the US Population
Rattan, P., Penrice, D. D., Ahn, J. C., Ferrer, A., Patnaik, M. M., Shah, V. H., Kamath, P. S., Mangaonkar, A. A., & Simonetto, D. A. (2021) · Hepatology Communications · doi:10.1002/hep4.1803 · Cited by 364 · see citing works
Telomeres and age-related disease: how telomere biology informs clinical paradigms
Armanios, M. Y. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66370 · Cited by 346 · see citing works
Self-citationIPF lung fibroblasts have a senescent phenotype
Álvarez, D., Cárdenes, N., Sellarés, J., Bueno, M., Corey, C., Hanumanthu, V. S., Peng, Y., D’Cunha, H., Sembrat, J., Nouraie, M., et al. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00220.2017 · Cited by 342 · see citing works
Self-citationRegulation of human telomerase in homeostasis and disease
Roake, C. M., & Artandi, S. E. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0234-z · Cited by 341 · see citing works
Meiners, S., Eickelberg, O., & Königshoff, M. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186914 · Cited by 340 · see citing works
Needham, B. L., Adler, N. E., Gregorich, S. E., Rehkopf, D. H., Lin, J., Blackburn, E. H., & Epel, E. S. (2013) · Social Science & Medicine · doi:10.1016/j.socscimed.2013.02.023 · Cited by 325 · see citing works
Self-citationCell Death in the Lung: The Apoptosis–Necroptosis Axis
Sauler, M., Bazan, I. S., & Lee, P. J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114320 · Cited by 325 · see citing works
Entringer, S., Buss, C., & Wadhwa, P. D. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.019 · Cited by 324 · see citing works
Genetic profiling of hepatocellular carcinoma using next-generation sequencing
Schulze, K., Nault, J., & Villanueva, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.035 · Cited by 318 · see citing works
Chilosi, M., Carloni, A., Rossi, A., & Poletti, V. E. (2013) · Translational research · doi:10.1016/j.trsl.2013.06.004 · Cited by 314 · see citing works
Telomeres and Telomere Length: A General Overview
Srinivas, N., Rachakonda, P. S., & Kumar, R. (2020) · Cancers · doi:10.3390/cancers12030558 · Cited by 313 · see citing works
Human telomerase: biogenesis, trafficking, recruitment, and activationPreprint
Schmidt, J. C., & Cech, T. R. (2015) · Genes & Development · doi:10.1101/gad.263863.115 · Cited by 301 · see citing works
Boonekamp, J. J., Mulder, G., Salomons, H. M., Dijkstra, C., & Verhulst, S. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2013.3287 · Cited by 289 · see citing works
Lindqvist, D., Epel, E. S., Mellon, S. H., Penninx, B. W., Révész, D., Verhoeven, J. E., Reus, V. I., Lin, J., Mahan, L., Hough, C. M., et al. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.05.007 · Cited by 285 · see citing works
Self-citationSocial disadvantage, genetic sensitivity, and children's telomere length
Mitchell, C., Hobcraft, J., McLanahan, S. S., Siegel, S. R., Berg, A., Brooks-Gunn, J., Garfinkel, I., & Notterman, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404293111 · Cited by 281 · see citing works
Diagnostic utility of telomere length testing in a hospital-based setting
Alder, J. K., Hanumanthu, V. S., Strong, M. A., Dezern, A. E., Stanley, S. E., Takemoto, C. M., Danilova, L., Applegate, C. D., Bolton, S. G., Mohr, D. W., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720427115 · Cited by 268 · see citing works
Self-citationTelomere-driven diseases and telomere-targeting therapies
Martínez, P., & Blasco, M. A. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610111 · Cited by 257 · see citing works
“Among the telomere syndromes, IPF is the most common condition associated with telomere dysfunction in humans (see text box; Armanios and Blackburn, 2012).”
BackgroundInfluentialCancer-associated TERT promoter mutations abrogate telomerase silencing
Chiba, K., Johnson, J. Z., Vogan, J. M., Wagner, T., Boyle, J. M., & Hockemeyer, D. F. (2015) · eLife · doi:10.7554/elife.07918 · Cited by 253 · see citing works
Telomerase at the intersection of cancer and aging
de Jesus, B. B., & Blasco, M. A. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.007 · Cited by 251 · see citing works
Aging Hallmarks: The Benefits of Physical Exercise
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., & Espregueira-Mendes, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00258 · Cited by 246 · see citing works
Basic Biology of Oxidative Stress and the Cardiovascular System
Sack, M. N., Fyhrquist, F., Saijonmaa, O. J., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.034 · Cited by 243 · see citing works
Codd, V., Denniff, M. J., Swinfield, C. E., Warner, S., Papakonstantinou, M., Sheth, S., Nanus, D. E., Budgeon, C. A., Musicha, C., Bountziouka, V. P., et al. (2022) · Nature Aging · doi:10.1038/s43587-021-00166-9 · Cited by 237 · see citing works
Juge, P., Borie, R., Kannengiesser, C., Gazal, S., Revy, P., Wémeau-Stervinou, L., Debray, M., Ottaviani, S., Marchand-Adam, S., Nathan, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02314-2016 · Cited by 234 · see citing works
Mitochondria in the signaling pathways that control longevity and health span
Akbari, M., Kirkwood, T. B. L., & Bohr, V. A. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100940 · Cited by 232 · see citing works
Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction
Povedano, J. M., Martinez, P., Flores, J. M., Mulero, F., & Blasco, M. A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.028 · Cited by 225 · see citing works
“To date, lung transplantation is the only therapeutic option for less than 5% of IPF patients with very severe disease (Lama, 2009).”
BackgroundInfluentialmTOR pathway activation drives lung cell senescence and emphysema
Houssaini, A., Breau, M., Kebe, K., Abid, S., Marcos, É., Lipskaia, L., Rideau, D., Parpaleix, A., Huang, J. L., Amsellem, V., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.93203 · Cited by 219 · see citing works
Telomere length behaves as biomarker of somatic redundancy rather than biological age
Boonekamp, J. J., Simons, M. J. P., Hemerik, L., & Verhulst, S. (2013) · Aging Cell · doi:10.1111/acel.12050 · Cited by 209 · see citing works
Telomerase Mechanism of Telomere Synthesis
Wu, R. A., Upton, H. E., Vogan, J. M., & Collins, K. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045019 · Cited by 208 · see citing works
Measuring telomere length and telomere dynamics in evolutionary biology and ecology
Nussey, D. H., Baird, D. M., Barrett, E. L. B., Boner, W., Fairlie, J., Gemmell, N. J., Hartmann, N., Horn, T., Haussmann, M. F., Olsson, M. M., et al. (2014) · Methods in Ecology and Evolution · doi:10.1111/2041-210x.12161 · Cited by 203 · see citing works
Current concepts in the pathophysiology and treatment of aplastic anemia
Young, N. S. (2013) · Hematology · doi:10.1182/asheducation-2013.1.76 · Cited by 199 · see citing works
TERT promoter mutations in telomere biology
Heidenreich, B., & Kumar, R. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2016.11.002 · Cited by 198 · see citing works
Telomerase mutations in smokers with severe emphysema
Stanley, S. E., Chen, J. J. L., Podlevsky, J. D., Alder, J. K., Hansel, N. N., Mathias, R. A., Qi, X., Rafaels, N. M., Wise, R. A., Silverman, E. K., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78554 · Cited by 196 · see citing works
Self-citationDiabetes, metabolic disease, and telomere length
Cheng, F., Carroll, L. M., Joglekar, M. V., Januszewski, A. S., Wong, K. K., Hardikar, A. A., Jenkins, A. J., & Ronald, C. W. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30365-x · Cited by 196 · see citing works
Telomere biology and age-related diseases
Herrmann, M., Pusceddu, I., März, W., & Herrmann, W. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0870 · Cited by 193 · see citing works
Lung transplantation in telomerase mutation carriers with pulmonary fibrosis
Silhan, L. L., Shah, P. D., Chambers, D. C., Snyder, L. D., Riise, G. C., Wagner, C. L., Hellström‐Lindberg, E., Orens, J. B., Mewton, J. F., Danoff, S. K., et al. (2014) · European Respiratory Journal · doi:10.1183/09031936.00060014 · Cited by 192 · see citing works
Self-citationGuen, T. L., Jullien, L., Touzot, F., Schertzer, M. J., Gaillard, L., Perderiset, M., Carpentier, W., Nitschké, P., Pïcard, C., Couillault, G., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt178 · Cited by 191 · see citing works
Romero, Y., Bueno, M., Ramı́rez, R., Álvarez, D., Sembrat, J., Goncharova, E. A., Rojas, M. M., Selman, M., Mora, A. L., & Pardo, A. (2016) · Aging Cell · doi:10.1111/acel.12514 · Cited by 190 · see citing works
Telomere Dysfunction Induces Sirtuin Repression that Drives Telomere-Dependent Disease
Amano, H., Chaudhury, A., Rodriguez-Aguayo, C., Lu, L., Akhanov, V., Catic, A., Popov, Y. V., Verdin, E., Johnson, H., Stossi, F., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.03.001 · Cited by 182 · see citing works
Oxidative guanine base damage regulates human telomerase activity
Fouquerel, E., Lormand, J., Bose, A., Lee, H.-T., Kim, G. S., Li, J., Sobol, R. W., Freudenthal, B. D., Myong, S., & Opresko, P. L. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3319 · Cited by 182 · see citing works
Exome Sequencing Identifies Mutant TINF2 in a Family With Pulmonary Fibrosis
Alder, J. K., Stanley, S. E., Wagner, C. L., Hamilton, M., Hanumanthu, V. S., & Armanios, M. Y. (2014) · CHEST Journal · doi:10.1378/chest.14-1947 · Cited by 181 · see citing works
Self-citationZalli, A., de Carvalho, L. A., Lin, J., Hamer, M., Erusalimsky, J. D., Blackburn, E. H., & Steptoe, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322145111 · Cited by 177 · see citing works
Self-citationTelomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis
Newton, C. A., Zhang, D., Oldham, J. M., Kozlitina, J., Ma, S., Martínez, F. J., Raghu, G., Noth, I., & Garcia, C. K. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1646oc · Cited by 177 · see citing works
Telomeropathies: An emerging spectrum disorder
Holohan, B., Wright, W. E., & Shay, J. W. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201401012 · Cited by 175 · see citing works
A method for measuring the distribution of the shortest telomeres in cells and tissues
Lai, T., Zhang, N., Noh, J., Mender, I., Tedone, E., Huang, E. E., Wright, W. E., Danuser, G. M., & Shay, J. W. (2017) · Nature Communications · doi:10.1038/s41467-017-01291-z · Cited by 171 · see citing works
Mice with hyper-long telomeres show less metabolic aging and longer lifespans
Muñoz-Lorente, M. A., Cano-Martin, A. C., & Blasco, M. A. (2019) · Nature Communications · doi:10.1038/s41467-019-12664-x · Cited by 168 · see citing works
Telomere length measurement as a clinical biomarker of aging and disease
Fasching, C. L. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1504274 · Cited by 166 · see citing works
Puterman, E., Gemmill, A., Karasek, D., Weir, D., Adler, N. E., Prather, A. A., & Epel, E. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525602113 · Cited by 165 · see citing works
Bär, C., de Jesus, B. B., Serrano, R., Tejera, A., Ayuso, E., Jimenez, V., Formentini, I., Bobadilla, M., Mizrahi, J., de Martino, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6863 · Cited by 162 · see citing works
Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis
Kannengiesser, C., Borie, R., Ménard, C., Réocreux, M., Nitschké, P., Gazal, S., Mal, H., Taillé, C., Cadranel, J. L., Nunès, H., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00040115 · Cited by 162 · see citing works
Needham, B. L., Rehkopf, D. H., Adler, N. E., Gregorich, S. E., Lin, J., Blackburn, E. H., & Epel, E. S. (2015) · Epidemiology · doi:10.1097/ede.0000000000000299 · Cited by 162 · see citing works
Self-citationGenome-wide Association Analysis in Humans Links Nucleotide Metabolism to Leukocyte Telomere Length
Li, C., Stoma, S., Lotta, L. A., Warner, S. C., Albrecht, E., Allione, A., Arp, P., Broer, L., Buxton, J. L., Alves, A. C., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.02.006 · Cited by 162 · see citing works
Heim, C. M., Entringer, S., & Buss, C. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.12.011 · Cited by 158 · see citing works
A null mutation in <i>SERPINE1</i> protects against biological aging in humans
Khan, S. S., Shah, S. J., Klyachko, E., Baldridge, A. S., Eren, M., Place, A. T., Aviv, A., Puterman, E., Lloyd-Jones, D. M., Heiman, M., et al. (2017) · Science Advances · doi:10.1126/sciadv.aao1617 · Cited by 157 · see citing works
The Telomere Deprotection Response Is Functionally Distinct from the Genomic DNA Damage Response
Cesare, A. J., Hayashi, M. T., Crabbe, L., & Karlseder, J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.006 · Cited by 155 · see citing works
Shalev, I., Moffitt, T. E., Braithwaite, A. W., Danese, A., Fleming, N. I., Goldman-Mellor, S., Harrington, H. L., Houts, R. M., Israel, S., Poulton, R., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.183 · Cited by 155 · see citing works
Blackburn, E. H., & Epel, E. S. (2012) · Nature · doi:10.1038/490169a · Cited by 155 · see citing works
Self-citationTelomere-associated aging disorders
Opresko, P. L., & Shay, J. W. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.009 · Cited by 155 · see citing works
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers
Diebel, L., & Rockwood, K. J. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01097-9 · Cited by 155 · see citing works
Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis
Kropski, J. A., Lawson, W. E., Young, L. R., & Blackwell, T. S. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010736 · Cited by 154 · see citing works
CRISPR/Cas 9 genome editing and its applications in organoids
Driehuis, E., & Clevers, H. C. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00410.2016 · Cited by 154 · see citing works
Hallmarks of progeroid syndromes: lessons from mice and reprogrammed cells
Carrero, D., Soria-Valles, C., & López-Otín, C. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024711 · Cited by 153 · see citing works
A Novel Dyskerin (DKC1) Mutation Is Associated With Familial Interstitial Pneumonia
Kropski, J. A., Mitchell, D. B., Markin, C. R., Polosukhin, V. V., Choi, L., Johnson, J. E., Lawson, W. E., Phillips, J. A., Cogan, J. D., Blackwell, T. S., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-2224 · Cited by 151 · see citing works
Proteostatic Control of Telomerase Function through TRiC-Mediated Folding of TCAB1
Freund, A., Zhong, F. L., Venteicher, A. S., Meng, Z., Veenstra, T. D., Frydman, J., & Artandi, S. E. (2014) · Cell · doi:10.1016/j.cell.2014.10.059 · Cited by 151 · see citing works
Long telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 151 · see citing works
Self-citationPuterman, E., Lin, J., Krauss, J., Blackburn, E. H., & Epel, E. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.70 · Cited by 150 · see citing works
Self-citationMutations, Cancer and the Telomere Length Paradox
Aviv, A., Anderson, J. J., & Shay, J. W. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.02.005 · Cited by 150 · see citing works
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Ramlee, M. K., Wang, J., Toh, W. H., & Li, S. (2016) · Genes · doi:10.3390/genes7080050 · Cited by 149 · see citing works
Familial Clonal Hematopoiesis in a Long Telomere Syndrome
DeBoy, E. A., Tassia, M. G., Schratz, K. E., Yan, S. M., Cosner, Z. L., McNally, E. J., Gable, D. L., Xiang, Z., Lombard, D. B., Antonarakis, E. S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300503 · Cited by 147 · see citing works
Self-citationStructure of Telomerase with Telomeric DNA
Jiang, J., Wang, Y., Sušac, L., Chan, H., Basu, R. S., Zhou, Z. H., & Feigon, J. F. (2018) · Cell · doi:10.1016/j.cell.2018.04.038 · Cited by 146 · see citing works
Borie, R., Kannengiesser, C., Hirschi, S., Pavec, J. L., Mal, H., Bergot, E., Jouneau, S., Naccache, J., Revy, P., Boutboul, D., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.11.010 · Cited by 144 · see citing works
Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT
Xi, L., & Cech, T. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku560 · Cited by 144 · see citing works
Structure of Tetrahymena telomerase reveals previously unknown subunits, functions, and interactions
Jiang, J.-S., Chan, H., Cash, D., Miracco, E., Loo, R. O., Upton, H. E., Cascio, D., Johnson, R. O., Collins, K., Loo, J., et al. (2015) · Science · doi:10.1126/science.aab4070 · Cited by 145 · see citing works
Transcriptional outcome of telomere signalling
Ye, J., Renault, V. M., Jamet, K., & Gilson, É. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3743 · Cited by 140 · see citing works
Povedano, J. M., Martinez, P., Serrano, R., Tejera, Á., Gómez-López, G., Bobadilla, M., Flores, J. M., Bosch, F., & Blasco, M. A. (2018) · eLife · doi:10.7554/elife.31299 · Cited by 139 · see citing works
Lapham, K., Kvale, M. N., Lin, J., Connell, S., Croen, L., Dispensa, B. P., Fang, L., Hesselson, S., Hoffmann, T. J., Iribarren, C., et al. (2015) · Genetics · doi:10.1534/genetics.115.178624 · Cited by 139 · see citing works
Self-citationMutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects
Simon, A. J., Lev, A., Zhang, Y., Weiss, B., Rylova, A., Eyal, E., Kol, N., Barel, O., Cesarkas, K., Soudack, M., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151618 · Cited by 136 · see citing works
RTEL1: functions of a disease-associated helicase
Vannier, J., Sarek, G., & Boulton, S. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.01.004 · Cited by 134 · see citing works
Aguado, J., Sola-Carvajal, A., Cancila, V., Revêchon, G., Ong, P. F., Jones-Weinert, C. W., Wallén Arzt, E., Lattanzi, G., Dreesen, O., Tripodo, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13018-3 · Cited by 133 · see citing works
Does oxidative stress shorten telomeres in vivo? A meta-analysis
Armstrong, E., & Boonekamp, J. J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101854 · Cited by 133 · see citing works
Zhang, Y., Mi, S., Hu, N., Doser, T. A., Sun, A., Ge, J., & Ren, J. T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.018 · Cited by 132 · see citing works
Cancer spectrum and outcomes in the Mendelian short telomere syndromes
Schratz, K. E., Haley, L. M., Danoff, S. K., Blackford, A. L., Dezern, A. E., Gocke, C. D., Duffield, A. S., & Armanios, M. Y. (2020) · Blood · doi:10.1182/blood.2019003264 · Cited by 131 · see citing works
Self-citationGenetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment
Kaur, A., Mathai, S. K., & Schwartz, D. A. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00154 · Cited by 130 · see citing works
European Respiratory Society statement on familial pulmonary fibrosis
Borie, R., Kannengiesser, C., Antoniou, K. M., Bonella, F., Crestani, B., Fabre, A., Froidure, A., Galvin, L., Griese, M., Grutters, J. C., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.01383-2022 · Cited by 130 · see citing works
Hepatopulmonary Syndrome Is a Frequent Cause of Dyspnea in the Short Telomere Disorders
Gorgy, A. I., Jonassaint, N. L., Stanley, S. E., Koteish, A. A., Dezern, A. E., Walter, J. E., Sopha, S. C., Hamilton, J. P., Hoover-Fong, J. E., Chen, A. R., et al. (2015) · CHEST Journal · doi:10.1378/chest.15-0825 · Cited by 129 · see citing works
Self-citationTelomere-mediated lung disease
Alder, J. K., & Armanios, M. Y. (2022) · Physiological Reviews · doi:10.1152/physrev.00046.2021 · Cited by 126 · see citing works
Self-citationTyrka, A. R., Carpenter, L. L., Kao, H.-T., Porton, B., Philip, N. S., Ridout, S. J., Ridout, K. K., & Price, L. H. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.04.002 · Cited by 125 · see citing works
- Authors
- Armanios, M., & Blackburn, E. H.
- Affiliations
- Johns Hopkins University (US)
- University of California, San Francisco (US)
- Corresponding author
- Armanios, Mary
- Venue
- Nature Reviews Genetics
- Published
- 2012-09-11
- Volume
- 13
- Issue
- 10
- Pages
- 693-704
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC3548426
- OpenAlex
- W1981775109
- Cited by
- 982
- References
- 128
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 50 · 2023: 63 · 2022: 68 · 2021: 92 · 2020: 74 · 2019: 79 · 2018: 81 · 2017: 84 · 2016: 82 · 2015: 80 · 2014: 71 · 2013: 59 · 2012: 8
- FWCI
- 7.50
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-02-12)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R21HL104345)
- National Cancer Institute (R01CA160433)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- telomere dysfunction, telomere maintenance, short telomeres, cellular aging, idiopathic pulmonary fibrosis, bone marrow failure, degenerative diseases, mode of inheritance, age-related diseases, telomere biology
- MeSH terms
- Animals, Humans, Models, Biological, Syndrome, Telomere, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Genetic Association Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review